Cancer Biology
Links shared publicly online about this topic
Zebrafish Journal Publishes Cancer Biology Special Issue
medicalnewstoday.com — “The zebrafish, a translucent fish often used as a model of human development and disease, offers unique advantages for studying the cause, growth, and spread of tumors using strategies and method” View full resource at medicalnewstoday.com
Most Recently Shared on January 9, 2010 at 1:04 pm By:
Zebrafish Journal Publishes Cancer Biology Special Issue http://mnt.to/3w5P
Landes Bioscience Journals: Cancer Biology & Therapy
landesbioscience.com — “Although treatments have improved patient prognosis in surgically resectable colorectal cancer, new effective drugs with improved safety profiles are needed to improve the currently poor outcomes of patients with recurrent or metastatic colorectal cancer. Quinacrine, a small molecule anti-malarial agent that has activity in giardiasis, lupus, prion disease, and used as a means of non-surgical sterilization, has shown cytotoxic activity across a broad range of cancers. Here, we evaluate the poten” View full resource at landesbioscience.com
Most Recently Shared on July 5, 2011 at 10:23 am By:
Wafik El-Deiry MD, PhD Oncologist, Hematologist, Physician, Doctor, PhD, and Internist
Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer http://t.co/6q96hPK
Landes Bioscience Journals: Cancer Biology & Therapy
landesbioscience.com — “Quinacrine has been widely explored in treatment of malaria, giardiasis, and rheumatic diseases. We find that quinacrine stabilizes p53 and induces p53-dependent and independent cell death. Treatment by quinacrine alone at concentrations of 10–20 mM for 1–2 d cannot kill hepatocellular carcinoma cells, such as HepG2, Hep3B, Huh7, which are also resistant to TRAIL. However, quinacrine renders these cells sensitive to treatment by TRAIL. Co-treatment of these cells with quinacrine and TRAIL induce” View full resource at landesbioscience.com
Most Recently Shared on July 5, 2011 at 10:19 am By:
Wafik El-Deiry MD, PhD Oncologist, Hematologist, Physician, Doctor, PhD, and Internist
Inexpensive antimalarial drug Quinacrine has potential as therapeutic in colorectal & liver cancer http://t.co/6q96hPK & http://t.co/uejpj9f
Landes Bioscience Journals: Cancer Biology & Therapy
landesbioscience.com — “Landes Bioscience” View full resource at landesbioscience.com
Most Recently Shared on May 7, 2010 at 10:10 pm By:
Wafik El-Deiry MD, PhD Oncologist, Hematologist, Physician, Doctor, PhD, and Internist
US cancer research saves lives, creates jobs, cont'd leadership in life sciences http://www.landesbioscience.com/journals/cbt/article/12279/
Landes Bioscience Journals: Cancer Biology & Therapy
landesbioscience.com — “Landes Bioscience” View full resource at landesbioscience.com
Most Recently Shared on December 17, 2010 at 1:15 am By:
Wafik El-Deiry MD, PhD Oncologist, Hematologist, Physician, Doctor, PhD, and Internist
Back to snowy Philadelphia after attending Kuwait Prize Ceremony in Kuwait http://www.landesbioscience.com/journals/cbt/article/14473/
Cancer Biology – Inside Cancer: A Multimedia Guide to Cancer
insidecancer.org — “Explore cancer biology, diagnosis, & treatment; follow molecular pathways to cancer with stunning animation and interviews. Use Teacher Center to build classroom presentations and more.” View full resource at insidecancer.org
Most Recently Shared on May 8, 2009 at 6:48 pm By:
Multimedia guide to cancer biology!! Neat site... http://budurl.com/3nwv
Schlessinger Appointed Director of New Cancer Biology Institute at Yale
opac.yale.edu — “Schlessinger Appointed Director of New Cancer Biology Institute at Yale” View full resource at opac.yale.edu
Most Recently Shared on December 13, 2010 at 2:47 pm By:
School of Medicine Medical School
Signal-transduction expert, pioneer of kinase inhibitors is first head of Yale's new Cancer Biology Institute. http://bit.ly/hSFJZN
Diabetes and cancer: A shared biological basis
sciencedaily.com — “Contrary to what you might think, cancer and diabetes appear to have some biology in common. According to a new study, a pathway that initially drew attention for its role in embryonic stem cells and cancer also influences the odds that mice develop or resist diabetes.” View full resource at sciencedaily.com
Most Recently Shared on September 30, 2011 at 3:41 pm By:
Scott Strumello Patient Expert
Diabetes and cancer: A shared biological basis http://t.co/lgygJELT
Diabetes and cancer: A shared biological basis
eurekalert.org — “Contrary to what you might think, cancer and diabetes appear to have some biology in common. According to a report in the September 30th issue of the Cell Press journal, Cell, a pathway that initially drew attention for its role in embryonic stem cells and cancer also influences the odds that mice develop or resist diabetes.” View full resource at eurekalert.org
Most Recently Shared on September 29, 2011 at 9:16 pm By:
Diabetes and cancer: A shared biological basis: ( Cell Press ) Contrary to what you might think, cancer and diab... http://t.co/NhtymtIR
Diabetes and cancer: A shared biological basis
sciencedaily.com — “Contrary to what you might think, cancer and diabetes appear to have some biology in common. According to a new study, a pathway that initially drew attention for its role in embryonic stem cells and cancer also influences the odds that mice develop or resist diabetes.” View full resource at sciencedaily.com
Most Recently Shared on September 30, 2011 at 3:21 pm By:
Diabetes and cancer: A shared biological basis: Contrary to what you might think, cancer and diabetes appear to ... http://t.co/PYffylXj
Biological computer destroys cancer cells
physorg.com — “Researchers led by ETH professor Yaakov Benenson and MIT professor Ron Weiss have successfully incorporated a diagnostic biological 'computer' network in human cells. This network recognizes certain cancer cells using logic combinations of five cancer-specific molecular factors, triggering cancer cells ...” View full resource at physorg.com
Most Recently Shared on September 1, 2011 at 6:57 pm By:
Biological computer destroys cancer cells http://t.co/IAQTuu0
Length Of Biological Marker Associated With Risk Of Cancer
medicalnewstoday.com — “A new study suggests that shorter length of leukocyte telomeres - chromosome markers of biological aging - are associated with an increased risk of cancer and death from cancer, according to a stu” View full resource at medicalnewstoday.com
Most Recently Shared on July 13, 2010 at 11:47 am By:
Length Of Biological Marker Associated With Risk Of Cancer: A new study suggests that shorter length of leukocyte ... http://mnt.to/f/3FZm
Biological Diversity Of Ovarian Cancer Lessens Value Of Screening
medicalnewstoday.com — “Cancer prevention experts have long been frustrated by the lack of a meaningful way to screen women for ovarian cancer. It is a relatively rare disease that often progresses with few symptoms unti” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 1:05 pm By:
MNT Ovarian Cancer Health News
Biological Diversity Of Ovarian Cancer Lessens Value Of Screening http://mnt.to/3P3K #ovariancancer
Discovery Of A Very Promising Biological Marker For Cancer
medicalnewstoday.com — “The follicle stimulating hormone, FSH, targets the human reproductive organs: the ovaries and testicles. In women, it stimulates maturation of ovarian follicles and production of oestrogens (via i” View full resource at medicalnewstoday.com
Most Recently Shared on October 22, 2010 at 1:05 pm By:
Discovery Of A Very Promising Biological Marker For Cancer http://mnt.to/3LyJ #cancer
Biologic Safety in IBD: Malignancy and Infection
hcplive.com — “A review of the data on risk of infection, malignancy, and death associated with therapies for IBD.” View full resource at hcplive.com
Most Recently Shared on October 20, 2010 at 4:55 pm By:
HCPLive_GastroCMS de Gastroenterology
Biologic Safety in IBD: Malignancy and Infection -Lewis @ #ACG2010 -http://hcp.lv/clqZvv
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Biology News
The latest biology news published daily. Articles from research centers, universities and prestigious journals.
-
Wafik El-Deiry MD, PhD
Wafik S. El-Diery, MD, PhD, is Chief Professor of Medicine-Hematology/Oncology, Rose Dunlap Division Chair in Hematology/Oncology, Associate Director for Translational Research, Cancer Institute at Penn State Hershey's Milton S. Hershey Medical Center. Dr El-Diery is a board certified hematologist. Dr El-Diery provides care for colorectal cancer and solid malignancies, as well as palliative care and participates in clinical trials.
Dr. El-Deiry is committed to translational cancer research focused on bringing new biomarkers and novel therapies into the clinic. He enjoys teaching, clinical work, serving on review panels, editorial boards (including as Founding Editor-in-Chief of Cancer Biology and Therapy since 2001) and training future scientists and clinicians. Dr. El-Deiry is a member of the American Society for Clinical Investigation, the American Association for Cancer Research, the American Society for Clinical Oncology, the Interurban Clinical Club, and the Association of American Physicians. -
Wafik El-Deiry MD, PhD
Wafik S. El-Diery, MD, PhD, is Chief Professor of Medicine-Hematology/Oncology, Rose Dunlap Division Chair in Hematology/Oncology, Associate Director for Translational Research, Cancer Institute at Penn State Hershey's Milton S. Hershey Medical Center. Dr El-Diery is a board certified hematologist. Dr El-Diery provides care for colorectal cancer and solid malignancies, as well as palliative care and participates in clinical trials.
Dr. El-Deiry is committed to translational cancer research focused on bringing new biomarkers and novel therapies into the clinic. He enjoys teaching, clinical work, serving on review panels, editorial boards (including as Founding Editor-in-Chief of Cancer Biology and Therapy since 2001) and training future scientists and clinicians. Dr. El-Deiry is a member of the American Society for Clinical Investigation, the American Association for Cancer Research, the American Society for Clinical Oncology, the Interurban Clinical Club, and the Association of American Physicians.
Advertisement
